<!DOCTYPE html>
<html lang="" xml:lang="">
<head>

  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <title>Chapter 17 Tubulopathies | Nephromaths</title>
  <meta name="description" content="How to use blood and urine electrolytes to diagnose and treat electrolyte and acid-base disorders." />
  <meta name="generator" content="bookdown 0.32 and GitBook 2.6.7" />

  <meta property="og:title" content="Chapter 17 Tubulopathies | Nephromaths" />
  <meta property="og:type" content="book" />
  
  <meta property="og:description" content="How to use blood and urine electrolytes to diagnose and treat electrolyte and acid-base disorders." />
  

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="Chapter 17 Tubulopathies | Nephromaths" />
  
  <meta name="twitter:description" content="How to use blood and urine electrolytes to diagnose and treat electrolyte and acid-base disorders." />
  

<meta name="author" content="Robert W Hunter" />


<meta name="date" content="2025-08-11" />

  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="apple-mobile-web-app-capable" content="yes" />
  <meta name="apple-mobile-web-app-status-bar-style" content="black" />
  
  
<link rel="prev" href="magnesium.html"/>
<link rel="next" href="renal-tubular-acidosis.html"/>
<script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<script src="https://cdn.jsdelivr.net/npm/fuse.js@6.4.6/dist/fuse.min.js"></script>
<link href="libs/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-table.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-clipboard.css" rel="stylesheet" />








<link href="libs/anchor-sections-1.1.0/anchor-sections.css" rel="stylesheet" />
<link href="libs/anchor-sections-1.1.0/anchor-sections-hash.css" rel="stylesheet" />
<script src="libs/anchor-sections-1.1.0/anchor-sections.js"></script>
<script src="libs/kePrint-0.0.1/kePrint.js"></script>
<link href="libs/lightable-0.0.1/lightable.css" rel="stylesheet" />
<link href="libs/bsTable-3.3.7/bootstrapTable.min.css" rel="stylesheet" />
<script src="libs/bsTable-3.3.7/bootstrapTable.js"></script>



<style type="text/css">
/* Used with Pandoc 2.11+ new --citeproc when CSL is used */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>

<link rel="stylesheet" href="style_RWH.css" type="text/css" />
</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li><a href="https://www.kidneyfish.net">KidneyFish</a></li>
<li><a href="./">Nephromaths</a></li>

<li class="divider"></li>
<li class="chapter" data-level="" data-path="index.html"><a href="index.html"><i class="fa fa-check"></i>Cover</a></li>
<li class="chapter" data-level="" data-path="disc.html"><a href="disc.html"><i class="fa fa-check"></i>Disclaimer</a></li>
<li class="chapter" data-level="" data-path="acknowledgements.html"><a href="acknowledgements.html"><i class="fa fa-check"></i>Acknowledgements</a></li>
<li class="part"><span><b>I Introduction</b></span></li>
<li class="chapter" data-level="1" data-path="intro.html"><a href="intro.html"><i class="fa fa-check"></i><b>1</b> Introduction</a>
<ul>
<li class="chapter" data-level="1.1" data-path="intro.html"><a href="intro.html#work-in-progress"><i class="fa fa-check"></i><b>1.1</b> Work in progress</a></li>
<li class="chapter" data-level="1.2" data-path="intro.html"><a href="intro.html#what-this-book-is---and-what-it-is-not"><i class="fa fa-check"></i><b>1.2</b> What this book is - and what it is not</a></li>
<li class="chapter" data-level="1.3" data-path="intro.html"><a href="intro.html#how-to-use-this-book"><i class="fa fa-check"></i><b>1.3</b> How to use this book</a></li>
</ul></li>
<li class="chapter" data-level="2" data-path="basic-concepts.html"><a href="basic-concepts.html"><i class="fa fa-check"></i><b>2</b> Basic Concepts</a>
<ul>
<li class="chapter" data-level="2.1" data-path="basic-concepts.html"><a href="basic-concepts.html#validity"><i class="fa fa-check"></i><b>2.1</b> Validity &amp; assumptions</a></li>
<li class="chapter" data-level="2.2" data-path="basic-concepts.html"><a href="basic-concepts.html#general-principles"><i class="fa fa-check"></i><b>2.2</b> General principles</a>
<ul>
<li class="chapter" data-level="2.2.1" data-path="basic-concepts.html"><a href="basic-concepts.html#balance"><i class="fa fa-check"></i><b>2.2.1</b> Balance</a></li>
<li class="chapter" data-level="2.2.2" data-path="basic-concepts.html"><a href="basic-concepts.html#testing-during-stress-normal-ranges"><i class="fa fa-check"></i><b>2.2.2</b> Testing during stress &amp; “normal ranges”</a></li>
<li class="chapter" data-level="2.2.3" data-path="basic-concepts.html"><a href="basic-concepts.html#renal-clearance-fractional-excretion"><i class="fa fa-check"></i><b>2.2.3</b> Renal clearance &amp; fractional excretion</a></li>
<li class="chapter" data-level="2.2.4" data-path="basic-concepts.html"><a href="basic-concepts.html#tmax"><i class="fa fa-check"></i><b>2.2.4</b> Tmax</a></li>
<li class="chapter" data-level="2.2.5" data-path="basic-concepts.html"><a href="basic-concepts.html#tonicity"><i class="fa fa-check"></i><b>2.2.5</b> Osmolarity, osmolality &amp; tonicity</a></li>
<li class="chapter" data-level="2.2.6" data-path="basic-concepts.html"><a href="basic-concepts.html#gaps"><i class="fa fa-check"></i><b>2.2.6</b> Gaps</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="3" data-path="general-approach-to-a-patient-with-electrolyte-disturbance.html"><a href="general-approach-to-a-patient-with-electrolyte-disturbance.html"><i class="fa fa-check"></i><b>3</b> General approach to a patient with electrolyte disturbance</a>
<ul>
<li class="chapter" data-level="3.1" data-path="general-approach-to-a-patient-with-electrolyte-disturbance.html"><a href="general-approach-to-a-patient-with-electrolyte-disturbance.html#vomit"><i class="fa fa-check"></i><b>3.1</b> Vomiting &amp; diarrhoea</a>
<ul>
<li class="chapter" data-level="3.1.1" data-path="general-approach-to-a-patient-with-electrolyte-disturbance.html"><a href="general-approach-to-a-patient-with-electrolyte-disturbance.html#electrolyte-content-of-body-fluids"><i class="fa fa-check"></i><b>3.1.1</b> Electrolyte content of body fluids</a></li>
<li class="chapter" data-level="3.1.2" data-path="general-approach-to-a-patient-with-electrolyte-disturbance.html"><a href="general-approach-to-a-patient-with-electrolyte-disturbance.html#vomiting"><i class="fa fa-check"></i><b>3.1.2</b> Vomiting</a></li>
<li class="chapter" data-level="3.1.3" data-path="general-approach-to-a-patient-with-electrolyte-disturbance.html"><a href="general-approach-to-a-patient-with-electrolyte-disturbance.html#quantitative-assessment-after-vomiting"><i class="fa fa-check"></i><b>3.1.3</b> Quantitative assessment after vomiting</a></li>
<li class="chapter" data-level="3.1.4" data-path="general-approach-to-a-patient-with-electrolyte-disturbance.html"><a href="general-approach-to-a-patient-with-electrolyte-disturbance.html#diarrhoea"><i class="fa fa-check"></i><b>3.1.4</b> Diarrhoea</a></li>
</ul></li>
<li class="chapter" data-level="3.2" data-path="general-approach-to-a-patient-with-electrolyte-disturbance.html"><a href="general-approach-to-a-patient-with-electrolyte-disturbance.html#drugs"><i class="fa fa-check"></i><b>3.2</b> Drugs</a></li>
<li class="chapter" data-level="3.3" data-path="general-approach-to-a-patient-with-electrolyte-disturbance.html"><a href="general-approach-to-a-patient-with-electrolyte-disturbance.html#iv-fluids-electrolyte-supplements"><i class="fa fa-check"></i><b>3.3</b> IV fluids &amp; electrolyte supplements</a></li>
<li class="chapter" data-level="3.4" data-path="general-approach-to-a-patient-with-electrolyte-disturbance.html"><a href="general-approach-to-a-patient-with-electrolyte-disturbance.html#diet"><i class="fa fa-check"></i><b>3.4</b> Diet</a></li>
<li class="chapter" data-level="3.5" data-path="general-approach-to-a-patient-with-electrolyte-disturbance.html"><a href="general-approach-to-a-patient-with-electrolyte-disturbance.html#basic-set-of-investigations"><i class="fa fa-check"></i><b>3.5</b> Basic set of investigations</a></li>
</ul></li>
<li class="part"><span><b>II Acid-base</b></span></li>
<li class="chapter" data-level="4" data-path="acid-base-chloride.html"><a href="acid-base-chloride.html"><i class="fa fa-check"></i><b>4</b> Acid-base &amp; chloride</a>
<ul>
<li class="chapter" data-level="4.1" data-path="acid-base-chloride.html"><a href="acid-base-chloride.html#acid-base-homeostasis"><i class="fa fa-check"></i><b>4.1</b> Acid-base homeostasis</a></li>
<li class="chapter" data-level="4.2" data-path="acid-base-chloride.html"><a href="acid-base-chloride.html#ph"><i class="fa fa-check"></i><b>4.2</b> pH</a></li>
<li class="chapter" data-level="4.3" data-path="acid-base-chloride.html"><a href="acid-base-chloride.html#adaptation"><i class="fa fa-check"></i><b>4.3</b> Adaptation</a></li>
<li class="chapter" data-level="4.4" data-path="acid-base-chloride.html"><a href="acid-base-chloride.html#renal-control-of-acid-base-homeostasis"><i class="fa fa-check"></i><b>4.4</b> Renal control of acid-base homeostasis</a>
<ul>
<li class="chapter" data-level="4.4.1" data-path="acid-base-chloride.html"><a href="acid-base-chloride.html#normal-renal-response-to-chronic-acidosis"><i class="fa fa-check"></i><b>4.4.1</b> Normal renal response to chronic acidosis</a></li>
<li class="chapter" data-level="4.4.2" data-path="acid-base-chloride.html"><a href="acid-base-chloride.html#renal-response-to-alkalosis"><i class="fa fa-check"></i><b>4.4.2</b> Renal response to alkalosis</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="5" data-path="metabolic-acidosis.html"><a href="metabolic-acidosis.html"><i class="fa fa-check"></i><b>5</b> Metabolic acidosis</a>
<ul>
<li class="chapter" data-level="5.1" data-path="metabolic-acidosis.html"><a href="metabolic-acidosis.html#serum-anion-osmolar-gaps"><i class="fa fa-check"></i><b>5.1</b> Serum anion &amp; osmolar gaps</a></li>
<li class="chapter" data-level="5.2" data-path="metabolic-acidosis.html"><a href="metabolic-acidosis.html#IxHCMA"><i class="fa fa-check"></i><b>5.2</b> Investigations in HCMA</a>
<ul>
<li class="chapter" data-level="5.2.1" data-path="metabolic-acidosis.html"><a href="metabolic-acidosis.html#urine-ph"><i class="fa fa-check"></i><b>5.2.1</b> Urine pH</a></li>
<li class="chapter" data-level="5.2.2" data-path="metabolic-acidosis.html"><a href="metabolic-acidosis.html#urine-anion-gap-osmolar-gap-ammonium"><i class="fa fa-check"></i><b>5.2.2</b> Urine anion gap, osmolar gap, ammonium</a></li>
</ul></li>
<li class="chapter" data-level="5.3" data-path="metabolic-acidosis.html"><a href="metabolic-acidosis.html#causes-of-a-metabolic-acidosis"><i class="fa fa-check"></i><b>5.3</b> Causes of a metabolic acidosis</a>
<ul>
<li class="chapter" data-level="5.3.1" data-path="metabolic-acidosis.html"><a href="metabolic-acidosis.html#approach-to-metabolic-acidosis"><i class="fa fa-check"></i><b>5.3.1</b> Approach to metabolic acidosis</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="6" data-path="metabolic-alkalosis-chloride-homeostasis.html"><a href="metabolic-alkalosis-chloride-homeostasis.html"><i class="fa fa-check"></i><b>6</b> Metabolic alkalosis (&amp; chloride homeostasis)</a>
<ul>
<li class="chapter" data-level="6.1" data-path="metabolic-alkalosis-chloride-homeostasis.html"><a href="metabolic-alkalosis-chloride-homeostasis.html#causes-of-a-metabolic-alkalosis"><i class="fa fa-check"></i><b>6.1</b> Causes of a metabolic alkalosis</a>
<ul>
<li class="chapter" data-level="6.1.1" data-path="metabolic-alkalosis-chloride-homeostasis.html"><a href="metabolic-alkalosis-chloride-homeostasis.html#specific-syndromes-and-their-mechanisms"><i class="fa fa-check"></i><b>6.1.1</b> Specific syndromes and their mechanisms</a></li>
</ul></li>
<li class="chapter" data-level="6.2" data-path="metabolic-alkalosis-chloride-homeostasis.html"><a href="metabolic-alkalosis-chloride-homeostasis.html#chloride"><i class="fa fa-check"></i><b>6.2</b> Chloride</a>
<ul>
<li class="chapter" data-level="6.2.1" data-path="metabolic-alkalosis-chloride-homeostasis.html"><a href="metabolic-alkalosis-chloride-homeostasis.html#chloride-depletion-alkalosis"><i class="fa fa-check"></i><b>6.2.1</b> Chloride-depletion alkalosis</a></li>
</ul></li>
</ul></li>
<li class="part"><span><b>III Water and sodium</b></span></li>
<li class="chapter" data-level="7" data-path="water-and-sodium.html"><a href="water-and-sodium.html"><i class="fa fa-check"></i><b>7</b> Water and sodium</a>
<ul>
<li class="chapter" data-level="7.1" data-path="water-and-sodium.html"><a href="water-and-sodium.html#total-body-water"><i class="fa fa-check"></i><b>7.1</b> Total body water</a></li>
<li class="chapter" data-level="7.2" data-path="water-and-sodium.html"><a href="water-and-sodium.html#plasma-sodium"><i class="fa fa-check"></i><b>7.2</b> Plasma sodium</a></li>
<li class="chapter" data-level="7.3" data-path="water-and-sodium.html"><a href="water-and-sodium.html#renal-water-excretion"><i class="fa fa-check"></i><b>7.3</b> Renal water excretion</a></li>
<li class="chapter" data-level="7.4" data-path="water-and-sodium.html"><a href="water-and-sodium.html#UOsm"><i class="fa fa-check"></i><b>7.4</b> Urine osmolality</a></li>
</ul></li>
<li class="chapter" data-level="8" data-path="hyponatraemia.html"><a href="hyponatraemia.html"><i class="fa fa-check"></i><b>8</b> Hyponatraemia</a>
<ul>
<li class="chapter" data-level="8.1" data-path="hyponatraemia.html"><a href="hyponatraemia.html#drug-causes-of-hyponatraemia"><i class="fa fa-check"></i><b>8.1</b> Drug causes of hyponatraemia</a></li>
<li class="chapter" data-level="8.2" data-path="hyponatraemia.html"><a href="hyponatraemia.html#correction-for-hyperglycaemia"><i class="fa fa-check"></i><b>8.2</b> Correction for hyperglycaemia</a></li>
<li class="chapter" data-level="8.3" data-path="hyponatraemia.html"><a href="hyponatraemia.html#urine-sodium"><i class="fa fa-check"></i><b>8.3</b> Urine sodium</a>
<ul>
<li class="chapter" data-level="8.3.1" data-path="hyponatraemia.html"><a href="hyponatraemia.html#fena"><i class="fa fa-check"></i><b>8.3.1</b> FE<sub>Na</sub></a></li>
<li class="chapter" data-level="8.3.2" data-path="hyponatraemia.html"><a href="hyponatraemia.html#feurate-as-an-alternative-index-of-volume-status"><i class="fa fa-check"></i><b>8.3.2</b> FE<sub>urate</sub> as an alternative index of volume status</a></li>
</ul></li>
<li class="chapter" data-level="8.4" data-path="hyponatraemia.html"><a href="hyponatraemia.html#free-water-clearance"><i class="fa fa-check"></i><b>8.4</b> Free water clearance</a>
<ul>
<li class="chapter" data-level="8.4.1" data-path="hyponatraemia.html"><a href="hyponatraemia.html#calculating-free-water-clearance"><i class="fa fa-check"></i><b>8.4.1</b> Calculating free water clearance</a></li>
<li class="chapter" data-level="8.4.2" data-path="hyponatraemia.html"><a href="hyponatraemia.html#clinical-utility-of-free-water-clearance"><i class="fa fa-check"></i><b>8.4.2</b> Clinical utility of free water clearance</a></li>
<li class="chapter" data-level="8.4.3" data-path="hyponatraemia.html"><a href="hyponatraemia.html#urine-flow-rate-in-hyponatraemia"><i class="fa fa-check"></i><b>8.4.3</b> Urine flow rate in hyponatraemia</a></li>
</ul></li>
<li class="chapter" data-level="8.5" data-path="hyponatraemia.html"><a href="hyponatraemia.html#siad"><i class="fa fa-check"></i><b>8.5</b> SIAD</a>
<ul>
<li class="chapter" data-level="8.5.1" data-path="hyponatraemia.html"><a href="hyponatraemia.html#diagnosis"><i class="fa fa-check"></i><b>8.5.1</b> Diagnosis</a></li>
<li class="chapter" data-level="8.5.2" data-path="hyponatraemia.html"><a href="hyponatraemia.html#subtypes"><i class="fa fa-check"></i><b>8.5.2</b> Subtypes</a></li>
<li class="chapter" data-level="8.5.3" data-path="hyponatraemia.html"><a href="hyponatraemia.html#treatment"><i class="fa fa-check"></i><b>8.5.3</b> Treatment</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="9" data-path="hypernatraemia.html"><a href="hypernatraemia.html"><i class="fa fa-check"></i><b>9</b> Hypernatraemia</a>
<ul>
<li class="chapter" data-level="9.1" data-path="hypernatraemia.html"><a href="hypernatraemia.html#causes-of-hypernatraemia"><i class="fa fa-check"></i><b>9.1</b> Causes of hypernatraemia</a></li>
<li class="chapter" data-level="9.2" data-path="hypernatraemia.html"><a href="hypernatraemia.html#diagnosis-in-hypernatraemia"><i class="fa fa-check"></i><b>9.2</b> Diagnosis in hypernatraemia</a></li>
<li class="chapter" data-level="9.3" data-path="hypernatraemia.html"><a href="hypernatraemia.html#treatment-of-hypernatraemia"><i class="fa fa-check"></i><b>9.3</b> Treatment of hypernatraemia</a></li>
</ul></li>
<li class="chapter" data-level="10" data-path="polyuria.html"><a href="polyuria.html"><i class="fa fa-check"></i><b>10</b> Polyuria</a>
<ul>
<li class="chapter" data-level="10.1" data-path="polyuria.html"><a href="polyuria.html#causes"><i class="fa fa-check"></i><b>10.1</b> Causes</a></li>
<li class="chapter" data-level="10.2" data-path="polyuria.html"><a href="polyuria.html#investigation-of-polyuria"><i class="fa fa-check"></i><b>10.2</b> Investigation of polyuria</a></li>
<li class="chapter" data-level="10.3" data-path="polyuria.html"><a href="polyuria.html#uses-for-copeptin-testing"><i class="fa fa-check"></i><b>10.3</b> Uses for copeptin testing</a>
<ul>
<li class="chapter" data-level="10.3.1" data-path="polyuria.html"><a href="polyuria.html#assay-details"><i class="fa fa-check"></i><b>10.3.1</b> Assay details</a></li>
<li class="chapter" data-level="10.3.2" data-path="polyuria.html"><a href="polyuria.html#polyuria-polydipsia-hypotonic-polyuria"><i class="fa fa-check"></i><b>10.3.2</b> Polyuria-polydipsia (hypotonic polyuria)</a></li>
<li class="chapter" data-level="10.3.3" data-path="polyuria.html"><a href="polyuria.html#hypernatraemia-1"><i class="fa fa-check"></i><b>10.3.3</b> Hypernatraemia</a></li>
<li class="chapter" data-level="10.3.4" data-path="polyuria.html"><a href="polyuria.html#hyponatraemia-1"><i class="fa fa-check"></i><b>10.3.4</b> Hyponatraemia</a></li>
</ul></li>
</ul></li>
<li class="part"><span><b>IV Potassium</b></span></li>
<li class="chapter" data-level="11" data-path="potassium.html"><a href="potassium.html"><i class="fa fa-check"></i><b>11</b> Potassium</a>
<ul>
<li class="chapter" data-level="11.1" data-path="potassium.html"><a href="potassium.html#quantification"><i class="fa fa-check"></i><b>11.1</b> Quantification</a>
<ul>
<li class="chapter" data-level="11.1.1" data-path="potassium.html"><a href="potassium.html#interpretation"><i class="fa fa-check"></i><b>11.1.1</b> Interpretation</a></li>
</ul></li>
<li class="chapter" data-level="11.2" data-path="potassium.html"><a href="potassium.html#TTKG"><i class="fa fa-check"></i><b>11.2</b> TTKG</a>
<ul>
<li class="chapter" data-level="" data-path="potassium.html"><a href="potassium.html#assumptions-pre-requisites"><i class="fa fa-check"></i>Assumptions &amp; pre-requisites</a></li>
<li class="chapter" data-level="" data-path="potassium.html"><a href="potassium.html#interpretation-1"><i class="fa fa-check"></i>Interpretation</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="12" data-path="hypokalaemia.html"><a href="hypokalaemia.html"><i class="fa fa-check"></i><b>12</b> Hypokalaemia</a>
<ul>
<li class="chapter" data-level="12.1" data-path="hypokalaemia.html"><a href="hypokalaemia.html#causes-of-hypokalaemia"><i class="fa fa-check"></i><b>12.1</b> Causes of hypokalaemia</a></li>
<li class="chapter" data-level="12.2" data-path="hypokalaemia.html"><a href="hypokalaemia.html#causes-of-k-loss"><i class="fa fa-check"></i><b>12.2</b> Causes of K loss</a></li>
<li class="chapter" data-level="12.3" data-path="hypokalaemia.html"><a href="hypokalaemia.html#diagnostic-approach"><i class="fa fa-check"></i><b>12.3</b> Diagnostic approach</a></li>
<li class="chapter" data-level="12.4" data-path="hypokalaemia.html"><a href="hypokalaemia.html#vomiting-1"><i class="fa fa-check"></i><b>12.4</b> Vomiting</a></li>
<li class="chapter" data-level="12.5" data-path="hypokalaemia.html"><a href="hypokalaemia.html#non-reasbsorbable-anions"><i class="fa fa-check"></i><b>12.5</b> Non-reasbsorbable anions</a></li>
<li class="chapter" data-level="12.6" data-path="hypokalaemia.html"><a href="hypokalaemia.html#hypokalaemic-periodic-paralysis"><i class="fa fa-check"></i><b>12.6</b> Hypokalaemic periodic paralysis</a></li>
</ul></li>
<li class="chapter" data-level="13" data-path="hyperkalaemia.html"><a href="hyperkalaemia.html"><i class="fa fa-check"></i><b>13</b> Hyperkalaemia</a>
<ul>
<li class="chapter" data-level="13.1" data-path="hyperkalaemia.html"><a href="hyperkalaemia.html#causes-of-hyperkalaemia"><i class="fa fa-check"></i><b>13.1</b> Causes of hyperkalaemia</a></li>
<li class="chapter" data-level="13.2" data-path="hyperkalaemia.html"><a href="hyperkalaemia.html#causes-of-spurious-hyper--and-hypokalaemia"><i class="fa fa-check"></i><b>13.2</b> Causes of spurious hyper- and hypokalaemia</a></li>
</ul></li>
<li class="part"><span><b>V Phosphate, Calcium, Magnesium</b></span></li>
<li class="chapter" data-level="14" data-path="phosphate.html"><a href="phosphate.html"><i class="fa fa-check"></i><b>14</b> Phosphate</a>
<ul>
<li class="chapter" data-level="14.1" data-path="phosphate.html"><a href="phosphate.html#urinary-phosphate"><i class="fa fa-check"></i><b>14.1</b> Urinary phosphate</a>
<ul>
<li class="chapter" data-level="14.1.1" data-path="phosphate.html"><a href="phosphate.html#general-approach"><i class="fa fa-check"></i><b>14.1.1</b> General approach</a></li>
<li class="chapter" data-level="14.1.2" data-path="phosphate.html"><a href="phosphate.html#TMPGFR"><i class="fa fa-check"></i><b>14.1.2</b> Measuring urinary phosphate and calculating TmP/GFR</a></li>
<li class="chapter" data-level="14.1.3" data-path="phosphate.html"><a href="phosphate.html#reference-ranges"><i class="fa fa-check"></i><b>14.1.3</b> Reference ranges</a></li>
</ul></li>
<li class="chapter" data-level="14.2" data-path="phosphate.html"><a href="phosphate.html#hypophosphataemia"><i class="fa fa-check"></i><b>14.2</b> Hypophosphataemia</a>
<ul>
<li class="chapter" data-level="14.2.1" data-path="phosphate.html"><a href="phosphate.html#consequences"><i class="fa fa-check"></i><b>14.2.1</b> Consequences</a></li>
<li class="chapter" data-level="14.2.2" data-path="phosphate.html"><a href="phosphate.html#causes-of-hypophosphataemia"><i class="fa fa-check"></i><b>14.2.2</b> Causes of hypophosphataemia</a></li>
<li class="chapter" data-level="14.2.3" data-path="phosphate.html"><a href="phosphate.html#notes-on-specific-causes"><i class="fa fa-check"></i><b>14.2.3</b> Notes on specific causes</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="15" data-path="calcium.html"><a href="calcium.html"><i class="fa fa-check"></i><b>15</b> Calcium</a>
<ul>
<li class="chapter" data-level="15.1" data-path="calcium.html"><a href="calcium.html#investigations-in-hypercalcaemia"><i class="fa fa-check"></i><b>15.1</b> Investigations in hypercalcaemia:</a></li>
<li class="chapter" data-level="15.2" data-path="calcium.html"><a href="calcium.html#urine-calcium"><i class="fa fa-check"></i><b>15.2</b> Urine calcium</a></li>
<li class="chapter" data-level="15.3" data-path="calcium.html"><a href="calcium.html#interpreting-the-results"><i class="fa fa-check"></i><b>15.3</b> Interpreting the results</a>
<ul>
<li class="chapter" data-level="15.3.1" data-path="calcium.html"><a href="calcium.html#unit-conversions"><i class="fa fa-check"></i><b>15.3.1</b> Unit conversions</a></li>
<li class="chapter" data-level="15.3.2" data-path="calcium.html"><a href="calcium.html#normal-calcium-excretion"><i class="fa fa-check"></i><b>15.3.2</b> Normal calcium excretion:</a></li>
<li class="chapter" data-level="15.3.3" data-path="calcium.html"><a href="calcium.html#hypercalciuria-e.g.-in-hyperpth-other-causes-of-hypercalcaemia-rta"><i class="fa fa-check"></i><b>15.3.3</b> Hypercalciuria (e.g. in hyperPTH, other causes of hypercalcaemia, RTA):</a></li>
<li class="chapter" data-level="15.3.4" data-path="calcium.html"><a href="calcium.html#hypocalciuria-e.g.-fhh-gitelman"><i class="fa fa-check"></i><b>15.3.4</b> Hypocalciuria (e.g. FHH, Gitelman):</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="16" data-path="magnesium.html"><a href="magnesium.html"><i class="fa fa-check"></i><b>16</b> Magnesium</a>
<ul>
<li class="chapter" data-level="16.1" data-path="magnesium.html"><a href="magnesium.html#mg-homeostasis"><i class="fa fa-check"></i><b>16.1</b> Mg homeostasis</a></li>
<li class="chapter" data-level="16.2" data-path="magnesium.html"><a href="magnesium.html#hypomagnesaemia"><i class="fa fa-check"></i><b>16.2</b> Hypomagnesaemia</a>
<ul>
<li class="chapter" data-level="16.2.1" data-path="magnesium.html"><a href="magnesium.html#consequences-1"><i class="fa fa-check"></i><b>16.2.1</b> Consequences</a></li>
<li class="chapter" data-level="16.2.2" data-path="magnesium.html"><a href="magnesium.html#differential-diagnosis-of-hypomagesaemia"><i class="fa fa-check"></i><b>16.2.2</b> Differential diagnosis of hypomagesaemia</a></li>
<li class="chapter" data-level="16.2.3" data-path="magnesium.html"><a href="magnesium.html#notes-on-specific-causes-1"><i class="fa fa-check"></i><b>16.2.3</b> Notes on specific causes</a></li>
</ul></li>
<li class="chapter" data-level="16.3" data-path="magnesium.html"><a href="magnesium.html#investigations"><i class="fa fa-check"></i><b>16.3</b> Investigations</a></li>
</ul></li>
<li class="part"><span><b>VI Tubulopathies</b></span></li>
<li class="chapter" data-level="17" data-path="tubulopathies.html"><a href="tubulopathies.html"><i class="fa fa-check"></i><b>17</b> Tubulopathies</a>
<ul>
<li class="chapter" data-level="17.1" data-path="tubulopathies.html"><a href="tubulopathies.html#inherited"><i class="fa fa-check"></i><b>17.1</b> Inherited</a>
<ul>
<li class="chapter" data-level="17.1.1" data-path="tubulopathies.html"><a href="tubulopathies.html#notes-on-some-of-the-inherited-tubulopathies"><i class="fa fa-check"></i><b>17.1.1</b> Notes on some of the inherited tubulopathies</a></li>
</ul></li>
<li class="chapter" data-level="17.2" data-path="tubulopathies.html"><a href="tubulopathies.html#acquired"><i class="fa fa-check"></i><b>17.2</b> Acquired</a></li>
<li class="chapter" data-level="17.3" data-path="tubulopathies.html"><a href="tubulopathies.html#tubulopathy-syndromes"><i class="fa fa-check"></i><b>17.3</b> Tubulopathy syndromes</a>
<ul>
<li class="chapter" data-level="17.3.1" data-path="tubulopathies.html"><a href="tubulopathies.html#interpretation-of-these-electrolyte-syndromes"><i class="fa fa-check"></i><b>17.3.1</b> Interpretation of these electrolyte syndromes</a></li>
</ul></li>
<li class="chapter" data-level="17.4" data-path="tubulopathies.html"><a href="tubulopathies.html#diagnostic-approach-in-suspected-tubulopathy"><i class="fa fa-check"></i><b>17.4</b> Diagnostic approach in suspected tubulopathy</a>
<ul>
<li class="chapter" data-level="17.4.1" data-path="tubulopathies.html"><a href="tubulopathies.html#fractional-excretions"><i class="fa fa-check"></i><b>17.4.1</b> Fractional excretions</a></li>
<li class="chapter" data-level="17.4.2" data-path="tubulopathies.html"><a href="tubulopathies.html#specialised-testing"><i class="fa fa-check"></i><b>17.4.2</b> Specialised testing</a></li>
</ul></li>
<li class="chapter" data-level="17.5" data-path="tubulopathies.html"><a href="tubulopathies.html#sjogren-syndrome"><i class="fa fa-check"></i><b>17.5</b> Sjogren syndrome</a></li>
<li class="chapter" data-level="17.6" data-path="tubulopathies.html"><a href="tubulopathies.html#lithium-associated-tubulopathy"><i class="fa fa-check"></i><b>17.6</b> Lithium-associated tubulopathy</a>
<ul>
<li class="chapter" data-level="17.6.1" data-path="tubulopathies.html"><a href="tubulopathies.html#pathogenesis"><i class="fa fa-check"></i><b>17.6.1</b> Pathogenesis</a></li>
<li class="chapter" data-level="17.6.2" data-path="tubulopathies.html"><a href="tubulopathies.html#polyuria-1"><i class="fa fa-check"></i><b>17.6.2</b> Polyuria</a></li>
<li class="chapter" data-level="17.6.3" data-path="tubulopathies.html"><a href="tubulopathies.html#tin"><i class="fa fa-check"></i><b>17.6.3</b> TIN</a></li>
<li class="chapter" data-level="17.6.4" data-path="tubulopathies.html"><a href="tubulopathies.html#podocytopathy"><i class="fa fa-check"></i><b>17.6.4</b> Podocytopathy</a></li>
</ul></li>
<li class="chapter" data-level="17.7" data-path="tubulopathies.html"><a href="tubulopathies.html#salt-wasting-tubulopathies"><i class="fa fa-check"></i><b>17.7</b> Salt-wasting tubulopathies</a></li>
</ul></li>
<li class="chapter" data-level="18" data-path="renal-tubular-acidosis.html"><a href="renal-tubular-acidosis.html"><i class="fa fa-check"></i><b>18</b> Renal tubular acidosis</a>
<ul>
<li class="chapter" data-level="18.1" data-path="renal-tubular-acidosis.html"><a href="renal-tubular-acidosis.html#classification-of-rta"><i class="fa fa-check"></i><b>18.1</b> Classification of RTA</a>
<ul>
<li class="chapter" data-level="18.1.1" data-path="renal-tubular-acidosis.html"><a href="renal-tubular-acidosis.html#pathogenesis-of-hypokalaemic-rta"><i class="fa fa-check"></i><b>18.1.1</b> Pathogenesis of hypokalaemic RTA</a></li>
<li class="chapter" data-level="18.1.2" data-path="renal-tubular-acidosis.html"><a href="renal-tubular-acidosis.html#pathogenesis-of-hyperkalaemic-rta"><i class="fa fa-check"></i><b>18.1.2</b> Pathogenesis of hyperkalaemic RTA</a></li>
<li class="chapter" data-level="18.1.3" data-path="renal-tubular-acidosis.html"><a href="renal-tubular-acidosis.html#associations"><i class="fa fa-check"></i><b>18.1.3</b> Associations</a></li>
<li class="chapter" data-level="18.1.4" data-path="renal-tubular-acidosis.html"><a href="renal-tubular-acidosis.html#investigation-of-suspected-rta"><i class="fa fa-check"></i><b>18.1.4</b> Investigation of suspected RTA</a></li>
<li class="chapter" data-level="18.1.5" data-path="renal-tubular-acidosis.html"><a href="renal-tubular-acidosis.html#causes-1"><i class="fa fa-check"></i><b>18.1.5</b> Causes</a></li>
</ul></li>
<li class="chapter" data-level="18.2" data-path="renal-tubular-acidosis.html"><a href="renal-tubular-acidosis.html#fanconi-syndrome"><i class="fa fa-check"></i><b>18.2</b> Fanconi syndrome</a></li>
</ul></li>
<li class="appendix"><span><b>Appendices</b></span></li>
<li class="chapter" data-level="A" data-path="app1.html"><a href="app1.html"><i class="fa fa-check"></i><b>A</b> Appendix 1 - notation &amp; abbreviations</a>
<ul>
<li class="chapter" data-level="A.1" data-path="app1.html"><a href="app1.html#notation"><i class="fa fa-check"></i><b>A.1</b> Notation</a></li>
<li class="chapter" data-level="A.2" data-path="app1.html"><a href="app1.html#glossary-of-abbreviations"><i class="fa fa-check"></i><b>A.2</b> Glossary of abbreviations</a></li>
</ul></li>
<li class="chapter" data-level="B" data-path="app2.html"><a href="app2.html"><i class="fa fa-check"></i><b>B</b> Appendix 2 - rules of thumb</a>
<ul>
<li class="chapter" data-level="B.1" data-path="app2.html"><a href="app2.html#ph-and-h"><i class="fa fa-check"></i><b>B.1</b> pH and [H<sup>+</sup>]</a></li>
<li class="chapter" data-level="B.2" data-path="app2.html"><a href="app2.html#urine-specific-gravity-and-uosm"><i class="fa fa-check"></i><b>B.2</b> Urine specific gravity and UOsm</a></li>
</ul></li>
<li class="chapter" data-level="C" data-path="appendix-3---whats-the-mechanism.html"><a href="appendix-3---whats-the-mechanism.html"><i class="fa fa-check"></i><b>C</b> Appendix 3 - what’s the mechanism?</a>
<ul>
<li class="chapter" data-level="C.1" data-path="appendix-3---whats-the-mechanism.html"><a href="appendix-3---whats-the-mechanism.html#mechanisms-in-drta-see-espn-clinical-practice-points-ndt-2021"><i class="fa fa-check"></i><b>C.1</b> Mechanisms in dRTA (see ESPN clinical practice points, NDT 2021):</a></li>
</ul></li>
<li class="chapter" data-level="D" data-path="appendix-4---references.html"><a href="appendix-4---references.html"><i class="fa fa-check"></i><b>D</b> Appendix 4 - references</a></li>
<li class="divider"></li>
<li><a href="https://github.com/rstudio/bookdown" target="blank">Published with bookdown</a></li>

</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./">Nephromaths</a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="tubulopathies" class="section level1 hasAnchor" number="17">
<h1><span class="header-section-number">Chapter 17</span> Tubulopathies<a href="tubulopathies.html#tubulopathies" class="anchor-section" aria-label="Anchor link to header"></a></h1>
<div id="inherited" class="section level2 hasAnchor" number="17.1">
<h2><span class="header-section-number">17.1</span> Inherited<a href="tubulopathies.html#inherited" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<p><img src="figures/tubulopathies_inherited.png" />
Other disorders not depicted here (and not necessarily classified as a pure “tubulopathy’):</p>
<ul>
<li>ADTKD (e.g. HNF1b etc.)<br />
</li>
<li>FHH (CaSR)<br />
</li>
<li>ciliopathies (ADPKD etc.)<br />
</li>
<li>metabolic disorders (oxalosis etc.)<br />
</li>
<li>endocrine disorders (GRA etc.)</li>
</ul>
<p><br>
<br></p>
<div id="notes-on-some-of-the-inherited-tubulopathies" class="section level3 hasAnchor" number="17.1.1">
<h3><span class="header-section-number">17.1.1</span> Notes on some of the inherited tubulopathies<a href="tubulopathies.html#notes-on-some-of-the-inherited-tubulopathies" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p>FHHNC = familial hypomagnesaemia with hypercalciuria and nephrocalcinosis</p>
<p>Inherited pRTA is very rare; inherited dRTA less so.<br />
Commonest cause of inherited Fanconi syndrome is cystinosis.<br />
XLD hypophosphataemic rickets is the commonest type; causes elevated FGF23 (phosphatonin).</p>
<p>X-linked hypercalciuric nephrolithiasis = Dent’s disease, XLR nephrolithiasis, XLR hypophosphataemia rickets, LMWH proteinuria (all CLCn5 mutations). Encodes chloride channel involved in endosomal acidification – therefore impaired endocytosis by megalin / cubulin. Defective endocytosis of vitD and PTH lead to calciuria.</p>
<p><br>
<br></p>
</div>
</div>
<div id="acquired" class="section level2 hasAnchor" number="17.2">
<h2><span class="header-section-number">17.2</span> Acquired<a href="tubulopathies.html#acquired" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<p><img src="figures/tubulopathies_acquired.png" /></p>
<p>Autoimmune associations with dRTA other than Sjogren are: SLE, PBC, AIH, thyroiditis.</p>
<p>Can get dRTA mimic secondary to low UNa (e.g. cirrhosis, heart failure, nephrotic syndrome). For complete list of 2ry causes see supplemental table 1 in <a href="https://doi:%2010.1093/ndt/gfab171">ESPN clinical practice points, NDT 2021</a>.</p>
<p><br>
<br></p>
</div>
<div id="tubulopathy-syndromes" class="section level2 hasAnchor" number="17.3">
<h2><span class="header-section-number">17.3</span> Tubulopathy syndromes<a href="tubulopathies.html#tubulopathy-syndromes" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<p><img src="figures/tubulopathies_syndromes.png" />
Other tubulopathy phenotypes:</p>
<ul>
<li>NDI and SIAD</li>
<li>nephrocalcinosis</li>
<li>recurrent stone-formers</li>
<li>CKD</li>
</ul>
<p><br>
<br></p>
<div id="interpretation-of-these-electrolyte-syndromes" class="section level3 hasAnchor" number="17.3.1">
<h3><span class="header-section-number">17.3.1</span> Interpretation of these electrolyte syndromes<a href="tubulopathies.html#interpretation-of-these-electrolyte-syndromes" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p>Causes of hyperchloraemic acidosis:</p>
<ul>
<li>diarrhoea / other lower GI losses (upH &lt; 5.5)<br />
</li>
<li>RTA<br />
</li>
<li>ureteric diversion<br />
</li>
<li>iatrogenic chloride excess</li>
</ul>
<p><br></p>
<p>Fanconi = glucose, urate, phosphate, aa, LWMP (uPCR &gt; 50 without uACR or RBP), vitD deficiency</p>
<p>Suspect incomplete dRTA if recurrent stones, nephrocalcinosis and borderline low or low-normal TCO2.</p>
<p>NB can get a transient Fanconi-type syndrome (without glycosuria) in untreated dRTA.</p>
<p><br>
<br></p>
</div>
</div>
<div id="diagnostic-approach-in-suspected-tubulopathy" class="section level2 hasAnchor" number="17.4">
<h2><span class="header-section-number">17.4</span> Diagnostic approach in suspected tubulopathy<a href="tubulopathies.html#diagnostic-approach-in-suspected-tubulopathy" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<p><img src="figures/tubulopathies_approach.png" /></p>
<p>Exogenous toxins = heavy metals, AA (i.e. herbal preps)
Endogenous toxins = paraproteins</p>
<p><br>
<br></p>
<div id="fractional-excretions" class="section level3 hasAnchor" number="17.4.1">
<h3><span class="header-section-number">17.4.1</span> Fractional excretions<a href="tubulopathies.html#fractional-excretions" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<ul>
<li>FECl &lt;0.5% = not a salt-losing tubulopathy (and therefore purging instead)</li>
<li>FEMg &gt;2 – 4% = renal wasting</li>
<li>FEPO4 &gt;10 – 20% = renal wasting</li>
</ul>
<p><br>
<br></p>
</div>
<div id="specialised-testing" class="section level3 hasAnchor" number="17.4.2">
<h3><span class="header-section-number">17.4.2</span> Specialised testing<a href="tubulopathies.html#specialised-testing" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p>Rarely a role for more specialist testing:</p>
<ul>
<li>urinary acidification test for recurrent stone-formers / nephrocalcinosis (NOT for frank acidosis)</li>
<li>thiazide test for Gitelman or Gordon (FECl)</li>
<li>urinary drug screen</li>
<li>exome testing (available in Scotland for Bartter &amp; Gitelman, Cystinuria, Nephrocalcinosis &amp; Nephrolithiasis (large panel), PHA1 (paeds), tubulopathies and RTA panel (very large panel)</li>
</ul>
<p><br>
<br></p>
</div>
</div>
<div id="sjogren-syndrome" class="section level2 hasAnchor" number="17.5">
<h2><span class="header-section-number">17.5</span> Sjogren syndrome<a href="tubulopathies.html#sjogren-syndrome" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<p>Spectrum of kidney disease including (often overlapping):</p>
<ul>
<li>pure tubulopathies<br />
</li>
<li>tubuolocentric lymphocytic TIN (= “extraglandular epithelialitis”)<br />
</li>
<li>IC MPGN of which 66% cryoglobulinaemia<br />
</li>
<li>cryoglobulinaemic vasculitis</li>
</ul>
<p><img src="figures/sjogren.png" />
<br>
<br></p>
<p>dRTA associated with Ro, La, hyperIg.<br />
NDI common but almost always well-compensated.<br />
GN associated with lymphoma.</p>
<p><br>
<br></p>
</div>
<div id="lithium-associated-tubulopathy" class="section level2 hasAnchor" number="17.6">
<h2><span class="header-section-number">17.6</span> Lithium-associated tubulopathy<a href="tubulopathies.html#lithium-associated-tubulopathy" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<p>Lithium causes:</p>
<ul>
<li>AVP-R (NDI)<br />
</li>
<li>(usually incomplete) dRTA<br />
</li>
<li>chronic TIN<br />
</li>
<li>podocytopathy<br />
</li>
<li>hyperCa (in 10% - can lead to parathyroid hyperplasia, therefore not easily reversible)</li>
</ul>
<p><br>
<br></p>
<div id="pathogenesis" class="section level3 hasAnchor" number="17.6.1">
<h3><span class="header-section-number">17.6.1</span> Pathogenesis<a href="tubulopathies.html#pathogenesis" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p>Renal toxicity largely explicable by effects in the distal tubule - but may have more pervasive effects on the rest of the renal tubule and the glomerulus.</p>
<p>In <a href="https://pubmed.ncbi.nlm.nih.gov/10906157/">humans</a> and <a href="https://pubmed.ncbi.nlm.nih.gov/3012187/">animals</a>, see chronic TIN with cortical and medullary cysts, predominantly arising from distal tubules (from Lectin stains). High prevalence of FSGS and global GS.</p>
<p><br></p>
<p>Chronic Li<sup>+</sup> leads to down-regulation of AQP2 expression from:<br />
- direct reduction in APQ2 <a href="https://pubmed.ncbi.nlm.nih.gov/16495377/">mRNA</a><br />
- direct effects on AQP2 <a href="https://pubmed.ncbi.nlm.nih.gov/21881002/">lysosomal degradation</a><br />
- increased PGE2 production by medullary interstitial cells<br />
- GSK3b inhibition &gt; beta-catenin &gt; cell-cycle arrest<br />
- <a href="https://pubmed.ncbi.nlm.nih.gov/24408872/">growth-arrest</a> of principle cells</p>
<p>AQP2 activity controlled by exo- and endo-cytosis, regulated by phosphorylation and ubiquitination of C-terminus.</p>
<p><br>
<br></p>
</div>
<div id="polyuria-1" class="section level3 hasAnchor" number="17.6.2">
<h3><span class="header-section-number">17.6.2</span> Polyuria<a href="tubulopathies.html#polyuria-1" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p>AVP-R in up to 40%. May <a href="https://pubmed.ncbi.nlm.nih.gov/848808/">persist long-term</a>.</p>
<p>Both AVP-D and primary polydipsia have been described in patients on chronic Li - therefore <a href="https://www.uptodate.com/contents/renal-toxicity-of-lithium/">may still require water deprivation test</a>. Or perhaps copeptin test?</p>
<p>Rx options:</p>
<ul>
<li>low Na diet<br />
</li>
<li>amiloride (preferable if continuing Li) - evidence from 20 patients!<br />
</li>
<li>thiazide<br />
</li>
<li>NSAIDs (indomethacin)<br />
</li>
<li>dDAVP<br />
</li>
<li>viagra (AJP 2012, Am J Nephron 2015)</li>
<li>tamoxifen (AJP 2018)</li>
</ul>
<p>Must closely monitor Li<sup>+</sup> levels if using diuretics (volume depletion &gt; enhanced PCT reabsorption of Li<sup>+</sup> &gt; higher Li<sup>+</sup> levels).</p>
<p><br>
<br></p>
</div>
<div id="tin" class="section level3 hasAnchor" number="17.6.3">
<h3><span class="header-section-number">17.6.3</span> TIN<a href="tubulopathies.html#tin" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p>CKD from chronic TIN in up to 20%.</p>
<p>Best data from <a href="https://pubmed.ncbi.nlm.nih.gov/22265699/">Lancet meta-analysis, 2012</a> and <a href="https://pubmed.ncbi.nlm.nih.gov/24503277/">Swedish registry report, 2014</a>.</p>
<p>eGFR c. 6 ml/min lower than matched controls.</p>
<p>Big increase in RR of ESKD (c. 8x) but absolute risk of ESKD remains reasonably low. Assuming ESKD risk of 0.1% in the general population, this would be around 0.8% on long-term Li<sup>+</sup>. (Matches well with reported rate in Lancet meta-analysis: 0.5%.) There are relatively few published data. In the Swedish registry report, ESKD occurred in 15% of the Li<sup>+</sup>-taking population. This may be due to the older age of these patients; in their age-restricted control population (over 55 yrs), there was an ESKD rate of 2%.</p>
<p>Usually other classical RFs for CKD. Mean duration of Li<sup>+</sup> therapy before ESKD was 27 years.</p>
<p><br>
<br></p>
</div>
<div id="podocytopathy" class="section level3 hasAnchor" number="17.6.4">
<h3><span class="header-section-number">17.6.4</span> Podocytopathy<a href="tubulopathies.html#podocytopathy" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p>Minimal change nephropathy <a href="https://www.uptodate.com/contents/renal-toxicity-of-lithium/">has been described</a>. Occurs within first few months of therapy and reversible on stopping Li<sup>+</sup>.</p>
<p>FSGS and global GS classically considered to be secondary to the tubulopathy but this may be a direct effect (e.g. <a href="https://pubmed.ncbi.nlm.nih.gov/10906157/">foot process effacement common</a>). Good evidence for direct effect on podocyte homeostasis in <a href="https://pubmed.ncbi.nlm.nih.gov/30679422/">rodent and fly models</a>: inhibition of GSK3 results in podocyte apoptosis.</p>
<p><br>
<br></p>
</div>
</div>
<div id="salt-wasting-tubulopathies" class="section level2 hasAnchor" number="17.7">
<h2><span class="header-section-number">17.7</span> Salt-wasting tubulopathies<a href="tubulopathies.html#salt-wasting-tubulopathies" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<p>The inherited salt-wasting tubulopathies (Bartter and Gitleman syndromes) are characterised by profound salt-wasting with salt-craving and hypokalaemic alkalosis from secondary hyperaldosteronism.</p>
<p>Gitelman commoner than Bartter. In adults, usually type 3 Bartter (overlap with Gitelman phenotype as ClC-Kb also expressed in DCT).</p>
<p>In <strong>Bartter</strong> syndrome, there is also:</p>
<ul>
<li><p><a href="https://pubmed.ncbi.nlm.nih.gov/33509356/">uncoupled tubuloglomerular feedback</a> (in the absence of NaKCl uptake by MD cells, the MD behaves as if there is profound volume depletion, stimulating PGE<sub>2</sub> and renin production - hence role for NSAIDs)</p></li>
<li><p>hypercalciuria and nephrocalcinosis</p></li>
<li><p>usually normal plasma Mg (except in some cases of type 3)</p></li>
</ul>
<p><br></p>
<p>In <strong>Gitelman</strong> syndrome, there is also:</p>
<ul>
<li>hypocalciuria<br />
</li>
<li>hypomagnesaemia<br />
</li>
<li>chondrocalcinosis<br />
</li>
<li>sometimes hypertension in adults</li>
</ul>
<p><br></p>
<p>Adults can develop CKD and secondary FSGS (when RASi usually used - otherwise avoid).</p>
<p><br></p>
<p>Liberal NaCl and K (+/- Mg) supplementation is required to target K &gt; 3 mM and Mg &gt; 0.6 mM. Risk of dangerous hypoK during intercurrent vomiting / diarrhoea. See <a href="https://pubmed.ncbi.nlm.nih.gov/33509356/">expert guidelines</a>.</p>
<!--

<br>
<br>

## Management
 
-->
<!-- 

### Supplements

- NEED TO DO: quantity of all supplements - uptodate?

- Slow K = KCl = start 2 tabs bd = less disgusting than SandoK  
- SlowNa = start 3 tabs tds and titrate up to 10 tabs tds = half daily losses in Gitelman  
- UroCitK = Kcitrate = start 2 tabs bd = crystals on wax tablet (appear in stool)  
- SMC approval for Sibnayal (K citrate + KHCO3 prolonged-release granules) = first licensed Rx for dRTA; better palatability in RCT  

NB K citrate improves bone health in healthy elderly!  

- MagTab SR = Mglactate = start 2 tabs bd  
- Organic Mg salts (aspartate or lactate) have better bioavailability than inorganic salts and therefore cause less diarrhoea  

<br>

Chronic hypoK probably okay; danger during intercurrent D&V.  

<br>
<br>

-->
<!-- ### Salt-losing nephropathy   -->
<!-- Rx of **Gitleman** (see [KDIGO controversies](http://dx.doi.org/10.1016/j.kint.2016.09.046) and UKKA / RCA guidelines):   -->
<!-- - target K 3.0 mM and Mg 0.60 mM   -->
<!-- - use KCl, starting 40 mmol/day   -->
<!-- - not on an empty stomach; can give in water or syrup   -->
<!-- - inorganic Mg salts > low bioavailability > osmotic diarrhoea   -->
<!-- - organic salts (aspartate, citrate, lactate) better   -->
<!-- - start 300 mg (~12 mmol) per day as SR tabets, bd - qds with meals   -->
<!-- - only rarely amiloride / MRAs / indometacin   -->
<!-- - almost always avoid RASi (aggravate NaCl wasting) - unless 2ry FSGS   -->
<!-- - sick day rules (get bloods checked whenever unwell) - see supplemental table in KDIGO paper   -->
<!-- - elective surgery if K > 3 and Mg > 0.5   -->

</div>
</div>
            </section>

          </div>
        </div>
      </div>
<a href="magnesium.html" class="navigation navigation-prev " aria-label="Previous page"><i class="fa fa-angle-left"></i></a>
<a href="renal-tubular-acidosis.html" class="navigation navigation-next " aria-label="Next page"><i class="fa fa-angle-right"></i></a>
    </div>
  </div>
<script src="libs/gitbook-2.6.7/js/app.min.js"></script>
<script src="libs/gitbook-2.6.7/js/clipboard.min.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="libs/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-clipboard.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": false,
"facebook": true,
"twitter": true,
"linkedin": false,
"weibo": false,
"instapaper": false,
"vk": false,
"whatsapp": false,
"all": ["facebook", "twitter", "linkedin", "weibo", "instapaper"]
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": {
"link": null,
"text": null
},
"history": {
"link": null,
"text": null
},
"view": {
"link": null,
"text": null
},
"download": null,
"search": {
"engine": "fuse",
"options": null
},
"toc": {
"collapse": "subsection"
}
});
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    var src = "true";
    if (src === "" || src === "true") src = "https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.9/latest.js?config=TeX-MML-AM_CHTML";
    if (location.protocol !== "file:")
      if (/^https?:/.test(src))
        src = src.replace(/^https?:/, '');
    script.src = src;
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>
</body>

</html>
